Lisann Pelzl

Post Doc
Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany

Presentation(s):

• PB0035 - Increased thrombus formation via procoagulant platelets in vaccine induced thrombotic thrombocytopenia (VITT)

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0096 - Sera from donors of COVID-19 convalescent plasma do not induce procoagulant phenotype in platelets

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0327 - Antibody-induced procoagulant platelets cause increased thrombus formation in heparin-induced thrombocytopenia

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 33.1 - Functional studies on the interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia

  Monday, July 11, 2022
  10:45 AM – 11:00 AM

• PB0529 - Investigations of the impact of different bleeding disorders using a humanized in vivo mouse model

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0879 - Inhibition of apoptosis during cold storage of platelet concentrates better maintains both platelet functionality and survival

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0993 - Measurement of procoagulant platelets in platelet-rich plasma by flow cytometer for the diagnosis of heparin-induced thrombocytopenia

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM